Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-04-20 Purchase | 2026-04-20 6:10 pm | Kailera Therapeutics Inc. | KLRA | BAIN CAPITAL INVESTORS LLC Bain Capital XIV General Partner LLC Bain Capital Fund XIV L.P. BCPE Perseus Investor GP LLC BCPE Perseus Investor LP 10% Owner | 8,398,438 | $16 | $134,375,008 | 26,255,581 (Indirect) | View |
| 2026-04-20 Purchase | 2026-04-20 6:08 pm | Kailera Therapeutics Inc. | KLRA | Koppel Adam Director 10% Owner | 1,562,500 | $16 | $25,000,000 | 22,621,568 (Indirect Direct) | View |
| 2026-04-20 Purchase | 2026-04-20 6:01 pm | Kailera Therapeutics Inc. | KLRA | Bain Capital Life Sciences Investors LLC Bain Capital Life Sciences IV General Partner LLC Bain Capital Life Sciences Fund IV L.P. BCLS Fund IV Investments GP LLC BCLS Fund IV Investments L.P. 10% Owner | 1,562,500 | $16 | $25,000,000 | 22,583,268 (Indirect) | View |
| 2026-04-20 Purchase | 2026-04-20 6:00 pm | Kailera Therapeutics Inc. | KLRA | Kaplan Andrew T. Director 10% Owner | 8,398,438 | $16 | $134,375,008 | 26,293,881 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-04-20 Conversion | 2026-04-20 6:10 pm | N/A N/A | Kailera Therapeutics Inc. | KLRA | BAIN CAPITAL INVESTORS LLC Bain Capital XIV General Partner LLC Bain Capital Fund XIV L.P. BCPE Perseus Investor GP LLC BCPE Perseus Investor LP 10% Owner | 17,857,143 | $0 | 26,255,581 (Indirect) | View |
| 2026-04-16 Option Award | 2026-04-20 6:08 pm | N/A 2036-04-16 | Kailera Therapeutics Inc. | KLRA | Koppel Adam Director 10% Owner | 38,300 | $0 | 22,621,568 (Direct) | View |
| 2026-04-20 Conversion | 2026-04-20 6:08 pm | N/A N/A | Kailera Therapeutics Inc. | KLRA | Koppel Adam Director 10% Owner | 21,020,768 | $0 | 22,621,568 (Indirect) | View |
| 2026-04-20 Conversion | 2026-04-20 6:01 pm | N/A N/A | Kailera Therapeutics Inc. | KLRA | Bain Capital Life Sciences Investors LLC Bain Capital Life Sciences IV General Partner LLC Bain Capital Life Sciences Fund IV L.P. BCLS Fund IV Investments GP LLC BCLS Fund IV Investments L.P. 10% Owner | 21,020,768 | $0 | 22,583,268 (Indirect) | View |
| 2026-04-16 Option Award | 2026-04-20 6:00 pm | N/A 2036-04-16 | Kailera Therapeutics Inc. | KLRA | Kaplan Andrew T. Director 10% Owner | 38,300 | $0 | 26,293,881 (Direct) | View |
| 2026-04-20 Conversion | 2026-04-20 6:00 pm | N/A N/A | Kailera Therapeutics Inc. | KLRA | Kaplan Andrew T. Director 10% Owner | 17,857,143 | $0 | 26,293,881 (Indirect) | View |
| 2026-04-16 Option Award | 2026-04-20 5:19 pm | N/A 2036-04-16 | Kailera Therapeutics Inc. | KLRA | Cloghessy Paula Chief People Officer | 120,000 | $0 | 120,000 (Direct) | View |
| 2026-04-16 Option Award | 2026-04-20 5:19 pm | N/A 2036-04-16 | Kailera Therapeutics Inc. | KLRA | Akamine Scott Chief Legal Officer | 120,000 | $0 | 120,000 (Direct) | View |
| 2026-04-16 Option Award | 2026-04-20 5:18 pm | N/A 2036-04-16 | Kailera Therapeutics Inc. | KLRA | Renaud Ronald C JR CEO & President | 600,000 | $0 | 600,000 (Direct) | View |
| 2026-04-16 Option Award | 2026-04-20 5:14 pm | N/A 2036-04-16 | Kailera Therapeutics Inc. | KLRA | Burgess Paul D. See Remarks | 200,000 | $0 | 200,000 (Direct) | View |
| 2026-04-16 Option Award | 2026-04-20 5:13 pm | N/A 2036-04-16 | Kailera Therapeutics Inc. | KLRA | MILLIGAN JOHN F Director | 38,300 | $0 | 38,300 (Direct) | View |
| 2026-04-16 Option Award | 2026-04-20 5:13 pm | N/A 2036-04-16 | Kailera Therapeutics Inc. | KLRA | Coleman Jamie Beth Chief Commercial Officer | 150,000 | $0 | 150,000 (Direct) | View |
| 2026-04-16 Option Award | 2026-04-20 5:10 pm | N/A 2036-04-16 | Kailera Therapeutics Inc. | KLRA | MACKAY MARTIN Director | 38,300 | $0 | 38,300 (Direct) | View |
| 2026-04-16 Option Award | 2026-04-20 5:08 pm | N/A 2036-04-16 | Kailera Therapeutics Inc. | KLRA | Wasserman Scott M. Chief Medical Officer | 200,000 | $0 | 200,000 (Direct) | View |
| 2026-04-16 Option Award | 2026-04-20 5:05 pm | N/A 2036-04-16 | Kailera Therapeutics Inc. | KLRA | Hite Christopher Director | 38,300 | $0 | 38,300 (Direct) | View |
| 2026-04-16 Option Award | 2026-04-20 5:04 pm | N/A 2036-04-16 | Kailera Therapeutics Inc. | KLRA | Clyburn Frank Director | 38,300 | $0 | 38,300 (Direct) | View |
| 2026-04-16 Option Award | 2026-04-20 5:01 pm | N/A 2036-04-16 | Kailera Therapeutics Inc. | KLRA | Pagan Douglas W. Chief Financial Officer | 200,000 | $0 | 200,000 (Direct) | View |
Ownership | 2026-04-16 8:29 pm | N/A N/A | Kailera Therapeutics Inc. | KLRA | Jiangsu Hengrui Pharmaceuticals Co. Ltd. 10% Owner | 0 | $0 | 11,511,853 (Indirect) | View |
Ownership | 2026-04-16 8:27 pm | N/A N/A | Kailera Therapeutics Inc. | KLRA | Koppel Adam Director 10% Owner | 0 | $0 | 21,020,768 (Indirect) | View |
Ownership | 2026-04-16 8:24 pm | N/A N/A | Kailera Therapeutics Inc. | KLRA | BAIN CAPITAL INVESTORS LLC Bain Capital XIV General Partner LLC Bain Capital Fund XIV L.P. BCPE Perseus Investor GP LLC BCPE Perseus Investor LP 10% Owner | 0 | $0 | 17,857,143 (Indirect) | View |
Ownership | 2026-04-16 8:24 pm | N/A N/A | Kailera Therapeutics Inc. | KLRA | Bain Capital Life Sciences Investors LLC Bain Capital Life Sciences IV General Partner LLC Bain Capital Life Sciences Fund IV L.P. BCLS Fund IV Investments GP LLC BCLS Fund IV Investments L.P. 10% Owner | 0 | $0 | 21,020,768 (Indirect) | View |
Ownership | 2026-04-16 8:19 pm | N/A N/A | Kailera Therapeutics Inc. | KLRA | Kaplan Andrew T. Director 10% Owner | 0 | $0 | 17,857,143 (Indirect) | View |
Ownership | 2026-04-16 7:49 pm | N/A 2034-09-19 | Kailera Therapeutics Inc. | KLRA | Burgess Paul D. See Remarks | 0 | $0 | 802,242 (Direct) | View |
Ownership | 2026-04-16 7:45 pm | N/A 2034-12-09 | Kailera Therapeutics Inc. | KLRA | Wasserman Scott M. Chief Medical Officer | 0 | $0 | 862,450 (Direct) | View |
Ownership | 2026-04-16 7:44 pm | N/A 2036-01-09 | Kailera Therapeutics Inc. | KLRA | Pagan Douglas W. Chief Financial Officer | 0 | $0 | 700,799 (Direct) | View |
Ownership | 2026-04-16 7:42 pm | N/A 2035-02-27 | Kailera Therapeutics Inc. | KLRA | Coleman Jamie Beth Chief Commercial Officer | 0 | $0 | 625,897 (Direct) | View |
Ownership | 2026-04-16 7:41 pm | N/A N/A | Kailera Therapeutics Inc. | KLRA | RTW INVESTMENTS LP WONG RODERICK 10% Owner | 0 | $0 | 10,276,820 (Indirect) | View |
Ownership | 2026-04-16 7:40 pm | N/A 2036-03-10 | Kailera Therapeutics Inc. | KLRA | MACKAY MARTIN Director | 0 | $0 | 170,194 (Direct) | View |
Ownership | 2026-04-16 7:39 pm | N/A 2035-06-03 | Kailera Therapeutics Inc. | KLRA | Hite Christopher Director | 0 | $0 | 170,194 (Direct) | View |
Ownership | 2026-04-16 7:35 pm | N/A 2034-09-19 | Kailera Therapeutics Inc. | KLRA | Cloghessy Paula Chief People Officer | 0 | $0 | 540,616 (Direct) | View |
Ownership | 2026-04-16 7:35 pm | N/A 2034-09-19 | Kailera Therapeutics Inc. | KLRA | Renaud Ronald C JR CEO & President | 0 | $0 | 3,918,467 (Direct) | View |
Ownership | 2026-04-16 7:30 pm | N/A 2035-11-05 | Kailera Therapeutics Inc. | KLRA | Clyburn Frank Director | 0 | $0 | 170,194 (Direct) | View |
Ownership | 2026-04-16 7:30 pm | N/A 2034-12-09 | Kailera Therapeutics Inc. | KLRA | Akamine Scott Chief Legal Officer | 0 | $0 | 551,562 (Direct) | View |
Ownership | 2026-04-16 7:27 pm | N/A 2034-12-09 | Kailera Therapeutics Inc. | KLRA | MILLIGAN JOHN F Director | 0 | $0 | 599,124 (Direct) | View |
Ownership | 2026-04-16 5:54 pm | N/A N/A | Kailera Therapeutics Inc. | KLRA | CANADA PENSION PLAN INVESTMENT BOARD CPP Investment Board Private Holdings (4) Inc. 10% Owner | 0 | $0 | 5,000,000 (Indirect) | View |
Ownership | 2026-04-16 5:45 pm | N/A N/A | Kailera Therapeutics Inc. | KLRA | Stuart Partners LLC 10% Owner | 0 | $0 | 1,428,571 (Direct) | View |